Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Metabolic and mitochondrial effects of antiretroviral drug exposure in pregnancy and postpartum: implications for fetal and future health.

Kirmse B, Baumgart S, Rakhmanina N.

Semin Fetal Neonatal Med. 2013 Feb;18(1):48-55. doi: 10.1016/j.siny.2012.10.005. Epub 2012 Nov 17.

PMID:
23164810
2.

Antiretroviral pharmacology: special issues regarding pregnant women and neonates.

Mirochnick M, Best BM, Clarke DF.

Clin Perinatol. 2010 Dec;37(4):907-27, xi. doi: 10.1016/j.clp.2010.08.006. Review.

PMID:
21078458
3.

Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.

Ekouevi DK, Touré R, Becquet R, Viho I, Sakarovitch C, Rouet F, Towne-Gold B, Fassinou P, Leroy V, Blanche S, Dabis F; Agence Nationale de Recherches Sur le SIDA 1201/1202 Ditrame Plus Study Group.

Pediatrics. 2006 Oct;118(4):e1071-7. Epub 2006 Sep 1.

4.

Antiretroviral therapy and mother-to-child transmission of HIV-1.

Newell ML, Thorne C.

Expert Rev Anti Infect Ther. 2004 Oct;2(5):717-32. Review.

PMID:
15482235
5.

[Recommendations issued by the Spanish Society of Pediatric Infectious Diseases for the follow-up of the child exposed to the human immunodeficiency virus and to antiretroviral drugs during pregnancy and the neonatal period].

Noguera Julian A, De José MI; Grupo de trabajo sobre infección por VIH en el niño de la Sociedad Española de Infectología Pediátrica (SEIP).

An Pediatr (Barc). 2012 Jun;76(6):360.e1-9. doi: 10.1016/j.anpedi.2012.01.007. Epub 2012 Mar 8. Spanish.

6.

International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.

Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N.

Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S42-55. Review.

PMID:
17825650
7.

Pharmacotherapy of perinatal HIV.

Capparelli E, Rakhmanina N, Mirochnick M.

Semin Fetal Neonatal Med. 2005 Apr;10(2):161-75. Epub 2005 Jan 20. Review.

PMID:
15701581
8.

[Tolerance of antiretroviral drugs during pregnancy].

Blanche S, Warszawski J.

Med Sci (Paris). 2013 Apr;29(4):383-8. doi: 10.1051/medsci/2013294011. Epub 2013 Apr 26. Review. French.

9.

Human immunodeficiency virus infection and pregnancy.

Petropoulou H, Stratigos AJ, Katsambas AD.

Clin Dermatol. 2006 Nov-Dec;24(6):536-42. Review.

PMID:
17113971
10.

Prevention of mother-to-child transmission.

Surjushe A, Maniar J.

Indian J Dermatol Venereol Leprol. 2008 May-Jun;74(3):200-7. Review. No abstract available.

11.

Evaluation and treatment of the human immunodeficiency virus-1--exposed infant.

King SM; American Academy of Pediatrics Committee on Pediatric AIDS; American Academy of Pediatrics Infectious Diseases and Immunization Committee.

Pediatrics. 2004 Aug;114(2):497-505.

PMID:
15286240
12.

Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States.

Jamieson DJ, Clark J, Kourtis AP, Taylor AW, Lampe MA, Fowler MG, Mofenson LM.

Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S26-32.

PMID:
17825647
13.

HIV in pregnancy.

Moodley J, Wennberg JL.

Curr Opin Obstet Gynecol. 2005 Apr;17(2):117-21. Review.

PMID:
15758601
14.

Screening for HIV in pregnant women: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation.

Chou R, Cantor AG, Zakher B, Bougatsos C.

Ann Intern Med. 2012 Nov 20;157(10):719-28. doi: 10.7326/0003-4819-157-10-201211200-00009. Review.

PMID:
23165663
15.

Raltegravir in pregnancy: a case series presentation.

Taylor N, Touzeau V, Geit M, Gisinger M, Egle A, Greil R, Rieger A, Zangerle R.

Int J STD AIDS. 2011 Jun;22(6):358-60. doi: 10.1258/ijsa.2011.010469.

PMID:
21680678
16.

Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2007.

Navér L, Bohlin AB, Albert J, Flamholc L, Gisslén M, Gyllensten K, Josephson F, Pehrson P, Sönnerborg A, Westling K, Lindgren S.

Scand J Infect Dis. 2008;40(6-7):451-61. doi: 10.1080/00365540801894787. Review.

PMID:
18584531
17.

[Antiretroviral agents and pregnancy: mitochondrial dysfunction and nucleoside analogs].

Loubeyre-Unique C, Gautier A, Vauzelle-Gardier C, Champart AM, Bavoux F.

Therapie. 2001 May-Jun;56(3):261-6. Review. French.

PMID:
11475805
18.

Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child.

Newell ML, Bunders MJ.

Curr Opin HIV AIDS. 2013 Sep;8(5):504-10. doi: 10.1097/COH.0b013e3283632b88. Review.

PMID:
23743789
19.

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

Bell DM, Brewinski MM, Holmes CB.

N Engl J Med. 2010 Nov 11;363(20):1969-70; author reply 1970. doi: 10.1056/NEJMc1009231#SA3. No abstract available.

PMID:
21067394
20.

Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women.

Mellins CA, Chu C, Malee K, Allison S, Smith R, Harris L, Higgins A, Zorrilla C, Landesman S, Serchuck L, Larussa P.

AIDS Care. 2008 Sep;20(8):958-68. doi: 10.1080/09540120701767208.

PMID:
18608073

Supplemental Content

Support Center